Single dose intranasal immunization with ISCOMATRIX vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract (Q45385326)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 February 2009

Language	Label	Description	Also known as
English	Single dose intranasal immunization with ISCOMATRIX vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract	scientific article published on 24 February 2009

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Single dose intranasal immunization with ISCOMATRIX vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract (English)

1 reference

Europe PubMed Central

14 December 2017

0 references

author name string

Megan T Sanders

1

1 reference

Europe PubMed Central

14 December 2017

Georgia Deliyannis

2

1 reference

Europe PubMed Central

14 December 2017

Martin J Pearse

3

1 reference

Europe PubMed Central

14 December 2017

Michael K McNamara

4

1 reference

Europe PubMed Central

14 December 2017

Lorena E Brown

5

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

24 February 2009

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

27

1 reference

Europe PubMed Central

14 December 2017

18

1 reference

Europe PubMed Central

14 December 2017

2475-2482

1 reference

Europe PubMed Central

14 December 2017

Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Contribution of plasma-derived molecules to mucosal immune defence, disease and repair in the airways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Needle-free vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Novel approaches to vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

The mucosal immune system: from fundamental concepts to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

ISCOM-based vaccines: the second decade.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

ISCOMATRIX adjuvant: a potent inducer of humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Murine model for evaluation of protective immunity to influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Influence of intravenous anesthesia on mucosal and systemic antibody responses to nasal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Tracking the tissue distribution of marker dye following intranasal delivery in mice and chinchillas: a multifactorial analysis of parameters affecting nasal retention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Kinetics of peptide uptake and tissue distribution following a single intranasal dose of peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Antigenic determinants of influenza virus hemagglutinin. XII. the epitopes of a synthetic peptide representing the C-terminus of HA1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

The role of nasopharyngeal lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Nasal lymphoid tissue in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Bronchus- and nasal-associated lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Characterization of a B220+ Lymphoid Cell Subpopulation with Immune Modulatory Functions in Nasal-Associated Lymphoid Tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (iscoms).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Dynamics of B-lymphocytes in the lungs of mice exposed to aerosolized influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

based on heuristic

inferred from DOI database lookup

Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.054

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.02.054

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45385326&oldid=2076301022"